Email Facebook Twitter

Please take part in our survey It takes 2 minutes and you could win an Apple iPad Air 2 (Terms and conditions apply). Dismiss Message
Add Phorm Corporation to quick picks

Phorm Corporation Share Price (PHRM)

Share Price Information for Phorm Corporation (PHRM)

Share Price: 10.75Bid: 10.50Ask: 11.00Change: 0.00 (0.00%)No Movement on Phorm Corp
Spread: 0.50Spread as %: 4.76%Open: 10.75High: 10.75Low: 10.75Yesterday’s Close: 10.75
InfoCFDs vs Share Trading - Download your Free Guide from London South East Markets
When trading CFDs, Forex, and Spread bets, it is possible to lose more than your initial deposit.

Phorm Corporation Limited Ord Npv (Di)

Phorm Corporation is listed in the FTSE AIM All-Share
Phorm Corporation is part of the Media sector

Share Price SpacerPrice

Share Price SpacerBid

Share Price SpacerAsk

Share Price SpacerChange

Share Price SpacerVolume

Share Price SpacerOpen

Share Price SpacerHigh

Share Price SpacerLow

Share Price SpacerClose

Share Price SpacerCurrency

Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GG 768.81m £82.65m 20,000

52 Week High 14.50 52 Week High Date 3-MAR-2014
52 Week Low 8.50 52 Week Low Date 21-AUG-2014

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
0 0 0 -1.108 -9.70 0.00 0.00

Trade Prc

Trade Type:

Trade Type:

Trade Type:

*Buys and Sells are calculated on the difference between the trade price and the current mid price. As such, they can occasionally be incorrect.

View more Phorm Corporation trades >>

Directors Deals for Phorm Corporation (PHRM)
Trade DateActionNotifierPriceCurrencyAmountHolding
Trade Notifier Information for Phorm Inc (Reg S)
Stephen Partridge-Hicks held the position of Non-Executive Director at Phorm Inc (Reg S) at the time of this trade.
 Stephen Partridge-Hicks
15-Nov-06Exercise of option
Trade Notifier Information for Phorm Inc (Reg S)
David Svendsen held the position of Non-Executive Chairman at Phorm Inc (Reg S) at the time of this trade.
 David Svendsen
20-Jul-06Exercise of option
Trade Notifier Information for Phorm Inc (Reg S)
Kent Ertugrul held the position of CEO at Phorm Inc (Reg S) at the time of this trade.
 Kent Ertugrul
View more Phorm Corporation directors dealings >>

Share Price
16 Jan '15
analysis of latest update
No Opinion

so a bit of ananlysis adverts served per user per day H1 2014 = 0.38 Q3 2014 (from oct update) = 0.49 H2 2014 = 0.23 % adverts requested served H1 2014 = 3.57% Q3 2014 (from oct update) = 4.21% H2 2014 = 3.11% Revenue per advert served H1 2014 = 0.020 cents Q3 2014 (from oct update) = 0.014 cents H2 2014 = 0.017 cents Revenue per user per month H1 2014 = 0.023 cents Q3 2014 (from oct update) = 0.021 cents H2 2014 = 0.012 cents I can provide the calculations if people require them the figures speak for themselves, not good reading and it could explain why phorm did not release the revenue or adverts served / impressions figures in december question is do we now see an RNS monday about fund raising? if we don't see it by mid week i would have to wonder if it will appear
16 Jan '15
Re:Impressive rns
No Opinion

*** and **** highlighted for "needs clarification" Implications? Note: * Revenues are unaudited. The exchange rate used for H2 2014 is GBP0.614:USD1.000 ***and the above figure includes amounts yet to be invoiced.*** The Company is also undertaking a major cost reduction programme that will result in a prioritisation of those markets where commercial traction is being achieved. ***As a result, the Company will be scaling back its operations in Turkey significantly*** and ****moving towards a remote cookie based platform.**** No mention of China??
16 Jan '15
No Opinion

Yes Phorm can be a good day trading share and probably will go up 20% plus today. The only trouble is that the company is still some way off making a profit so the question is "how many more equity raisings will be required over the next 2-3 years before/if this happens?"
16 Jan '15
Impressive rns
No Opinion

Reporting better than expected revenue from update in the 8th dec. new product and new market... Should give a nice profit for day traders in my
29 Nov '14
my latest observations
No Opinion

so in the last week the mid has dropped steadilly from 10.75 to 9.75 about 9% drop still no sign of new cash or a share issue time is running short for phorm to raise cash or provide good news in the form of impressive revenue to try and get interest in any possible share issue moving the fact there has been no revenue figures and reportedly on another forum (though not proved and no evidence provided to back up the claim) lack of interest in a share issue is interesting, i would assume anyone who would be interest in or offered the option to partake would have to be appraised of certain information relevant information on which to make a decision to partake in a share issue if and i say IF a share issue has been offered around and no uptake has occurred it could be seen as an indication of how bad the prospects are for phorm and its finances but it is a long time after the predicted running out of cash based on the last cash burn and cash in the bank from phorm there are a number of possible answers 1:- phorm have generated more revenue than anticipated (if this was the case we would have heard about it by rns so i don't think it likely) 2:- cash burn has been reduced and cash has lasted longer than expected (possible but again i think unlikely) 3:- some independant injection of cash rather than a share issue (unlikely not sure if possible without some form of notification) 4:- the cash call / share issue has not yet taken place (possible but no evidence to confirm or deny) 5:- the cash call / share issue has been attempted and failed (possible but no evidence to confirm or deny) so most likey are the last two but no evidence to support either, as normal only time will tell. we have the rampers on the other forum who would have us believe option 4 is correct but they have a history of mis-information we also have a new poster on the same thread on the other forum who has made the unsubstantiated claims that phorm have attempted and failed to raise cash, they have no history for me to judge them for or against. the only information presented that could be verified has been that which is available to anyone with level 2 access so apart from the current SP slide there is no real evidence regarding a share issue but it is likely cash is at a criticle level based on the last figures provided by phorm, and up to now those predicitions based on phorms figures appear to have been accurate to a week or so so what information do we have still not granted patents, still not enough revenue in a year to cover a single months cash burn even the optimistic predictions of mr bigger show phorm will still need regular cash transfusions to keep it alive for 18-24 months before it "MAY" be possible to support its self but how much more cash is that going to take? £40m-£50m and that is a ball park figure based on current cash burn rates and a linear increase in revenue as per mr biggers pre
23 Nov '14
are phorm struggling to get funding
No Opinion

comments on another forum seems to suggest phorm are not finding any takers for the latest round of funding / share issues to quote "it don't look like no one is coming forward from the book build, looks as if they may have to lower the price again or there will be trouble ahead" and later "it looks as if the fat woman is singing here, sold mine today, best to move out of this, don't want to get caught out on a suspension and lose it all" anyone have any other information?

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Phorm Corporation (PHRM) >>
Please Login or Register to post messages

Share Trading BrochureRequest your Free brochures on share dealing, spread betting and CFDs

Sign up for Live Prices

Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy

Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.